Deal Makers of Japan, Volume 3
The Deal Makers of Japan series aims to bridge the gap and offer insight to a global biopharma audience to the Japanese pharma industry. We are pleased to present the third volume of the Deal Makers of Japan - Exclusive Interviews with Japan’s best dealmakers, featuring Shionogi. This piece highlights how they are turning COVID complexity into opportunity and their long-term transformation strategy in response to the rapidly changing market.
We were excited to have the opportunity to sit down with Ms. Takuko Sawada, Vice Chairperson at Shionogi, and conduct an in-depth interview to understand the stories and perspectives of Shionogi. During our conversation, we covered a variety of topics including corporate strategy, operation, diversity and talent management, and R&D strategy. We hope to provide the reader with a closer look at a leading Japanese pharma to understand its mindset and culture.
We at Locust Walk hope the reader will gain inspiration from Shionogi’s story and a new perspective on collaborating and doing a deal with Japanese pharmaceutical companies.